Annual Shareholders Equity
$243.12 M
+$21.90 M+9.90%
December 31, 2023
Summary
- As of February 23, 2025, ATXS annual stockholders equity is $243.12 million, with the most recent change of +$21.90 million (+9.90%) on December 31, 2023.
- During the last 3 years, ATXS annual shareholders equity has risen by +$202.45 million (+497.79%).
- ATXS annual shareholders equity is now at all-time high.
Performance
ATXS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$341.65 M
-$5.42 M-1.56%
September 30, 2024
Summary
- As of February 23, 2025, ATXS quarterly stockholders equity is $341.65 million, with the most recent change of -$5.42 million (-1.56%) on September 30, 2024.
- Over the past year, ATXS quarterly shareholders equity has increased by +$157.18 million (+85.20%).
- ATXS quarterly shareholders equity is now -7.09% below its all-time high of $367.74 million, reached on March 31, 2024.
Performance
ATXS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ATXS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.9% | +85.2% |
| 3 y3 years | +497.8% | +85.2% |
| 5 y5 years | +595.8% | +85.2% |
ATXS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +98.8% | -7.1% | +243.7% |
| 5 y | 5-year | at high | +580.6% | -7.1% | +437.8% |
| alltime | all time | at high | +432.8% | -7.1% | +437.8% |
Astria Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $341.65 M(-1.6%) |
| Jun 2024 | - | $347.08 M(-5.6%) |
| Mar 2024 | - | $367.74 M(+51.3%) |
| Dec 2023 | $243.12 M(+9.9%) | $243.12 M(+31.8%) |
| Sep 2023 | - | $184.48 M(-7.9%) |
| Jun 2023 | - | $200.40 M(-5.2%) |
| Mar 2023 | - | $211.36 M(-4.5%) |
| Dec 2022 | $221.22 M(+80.9%) | $221.22 M(+96.0%) |
| Sep 2022 | - | $112.87 M(+13.5%) |
| Jun 2022 | - | $99.42 M(-9.4%) |
| Mar 2022 | - | $109.69 M(-10.3%) |
| Dec 2021 | $122.31 M(+200.7%) | $122.31 M(-6.2%) |
| Sep 2021 | - | $130.43 M(-4.7%) |
| Jun 2021 | - | $136.90 M(-235.3%) |
| Mar 2021 | - | -$101.14 M(-348.7%) |
| Dec 2020 | $40.67 M(+13.9%) | $40.67 M(-17.5%) |
| Sep 2020 | - | $49.31 M(-3.0%) |
| Jun 2020 | - | $50.86 M(-5.3%) |
| Mar 2020 | - | $53.71 M(+50.4%) |
| Dec 2019 | $35.72 M | $35.72 M(-6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $38.27 M(-11.7%) |
| Jun 2019 | - | $43.36 M(-13.1%) |
| Mar 2019 | - | $49.87 M(+42.7%) |
| Dec 2018 | $34.94 M(+196.3%) | $34.94 M(-13.8%) |
| Sep 2018 | - | $40.52 M(-11.6%) |
| Jun 2018 | - | $45.81 M(+254.3%) |
| Mar 2018 | - | $12.93 M(+9.7%) |
| Dec 2017 | $11.79 M(-59.5%) | $11.79 M(-24.7%) |
| Sep 2017 | - | $15.66 M(-27.3%) |
| Jun 2017 | - | $21.55 M(-10.0%) |
| Mar 2017 | - | $23.95 M(-17.6%) |
| Dec 2016 | $29.09 M(-42.4%) | $29.09 M(-21.1%) |
| Sep 2016 | - | $36.86 M(+12.3%) |
| Jun 2016 | - | $32.81 M(-21.4%) |
| Mar 2016 | - | $41.72 M(-17.4%) |
| Dec 2015 | $50.49 M(-169.1%) | $50.49 M(-15.2%) |
| Sep 2015 | - | $59.54 M(-11.9%) |
| Jun 2015 | - | $67.59 M(+401.1%) |
| Mar 2015 | - | $13.49 M(-118.5%) |
| Dec 2014 | -$73.05 M(+40.0%) | -$73.05 M |
| Dec 2013 | -$52.18 M | - |
FAQ
- What is Astria Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Astria Therapeutics?
- What is Astria Therapeutics annual shareholders equity year-on-year change?
- What is Astria Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Astria Therapeutics?
- What is Astria Therapeutics quarterly shareholders equity year-on-year change?
What is Astria Therapeutics annual stockholders equity?
The current annual shareholders equity of ATXS is $243.12 M
What is the all time high annual shareholders equity for Astria Therapeutics?
Astria Therapeutics all-time high annual stockholders equity is $243.12 M
What is Astria Therapeutics annual shareholders equity year-on-year change?
Over the past year, ATXS annual stockholders equity has changed by +$21.90 M (+9.90%)
What is Astria Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ATXS is $341.65 M
What is the all time high quarterly shareholders equity for Astria Therapeutics?
Astria Therapeutics all-time high quarterly stockholders equity is $367.74 M
What is Astria Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ATXS quarterly stockholders equity has changed by +$157.18 M (+85.20%)